当前位置: X-MOL 学术J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
Journal of Medicinal Chemistry ( IF 7.3 ) Pub Date : 2018-03-01 00:00:00 , DOI: 10.1021/acs.jmedchem.8b00051
Maarten L. J. Doornbos 1 , Xuesong Wang 1 , Sophie C. Vermond 1 , Luc Peeters 2 , Laura Pérez-Benito 3, 4 , Andrés A. Trabanco 3 , Hilde Lavreysen 2 , José María Cid 3 , Laura H. Heitman 1 , Gary Tresadern 3 , Adriaan P. IJzerman 1
Affiliation  

Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach to understand binding modes, mechanism of action, pharmacology, and even facilitate structure elucidation. We report the first covalent positive allosteric modulator (PAM) for a class C GPCR, the mGlu2 receptor. Three putatively covalent mGlu2 PAMs were designed and synthesized. Pharmacological characterization identified 2 to bind the receptor covalently. Computational modeling combined with receptor mutagenesis revealed T7917.29×30 as the likely position of covalent interaction. We show how this covalent ligand can be used to characterize the PAM binding mode and that it is a valuable tool compound in studying receptor function and binding kinetics. Our findings advance the understanding of the mGlu2 PAM interaction and suggest that 2 is a valuable probe for further structural and chemical biology approaches.

中文翻译:

代谢型谷氨酸受体的共价变构探针2:设计,合成和药理学表征。

用小分子共价标记G蛋白偶联受体(GPCR)是了解结合模式,作用机理,药理作用甚至促进结构阐明的有力方法。我们报告的第一个共价阳性变构调节剂(PAM)为C类GPCR,mGlu 2受体。设计并合成了三个推定共价的mGlu 2 PAM。药理学特征鉴定为2与受体共价结合。计算模型结合受体诱变显示T791 7.29×30作为共价相互作用的可能位置。我们展示了这种共价配体如何用于表征PAM结合模式,并且它是研究受体功能和结合动力学的有价值的工具化合物。我们的发现提高了对mGlu 2 PAM相互作用的理解,并表明2是进一步的结构和化学生物学方法的有价值的探针。
更新日期:2018-03-01
down
wechat
bug